|
|
Tuberculosis Control in Nepal and India: Are National Programmes Using Correct Treament Regimens in Use?
|
|
|
|
The paper examines and compares these regimens and the reactions to
them in the context of Nepal and India. This is done from the perspective of an attempt
to understand the market and other forces driving the sales of TB drugs, which waree
addressed in the first section. The majority of TB patients receive their treatment
outside the public sector. The authors argue that while the scientific evidence may be
equivocal over the efficacy of the national DOTS regimens, policy decisions should
be made in the light of this local context. Secondly, they examine the reaction to the
prescribed national regimens from practitioners in the private sector in Nepal and
India. Although the regimen decisions were made in part because of cost implications,
the very choice of the regimens themselves has hampered efforts to ‘integrate’ the
non-public sector into an overall attempt to control tuberculosis.
|
|
|
by Ian Harper | Vol.2, No.1,2,3, -2009-Tracing Pharmaceuticals in South Asia: Drugs, Doctors and Public Policy
|
View
Download
|
|
|
|
|
|
|
|
|